Literature DB >> 681148

Chronic active liver disease: experiences with 17 patients.

M J Walsh, M O'Brien, C F McCarthy.   

Abstract

Entities:  

Mesh:

Year:  1978        PMID: 681148     DOI: 10.1007/BF02939408

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  16 in total

1.  Failure to transfer-factor therapy in chronic active type B hepatitis.

Authors:  M J Tong; J S Nystrom; A G Redeker; G J Marshall
Journal:  N Engl J Med       Date:  1976-07-22       Impact factor: 91.245

2.  Sex, ascites and alcoholism in survival of patients with cirrhosis. Effect of prednisone.

Authors: 
Journal:  N Engl J Med       Date:  1974-08-08       Impact factor: 91.245

Review 3.  Chronic active liver disease reexamined: prognosis hopeful.

Authors:  W H Summerskill
Journal:  Gastroenterology       Date:  1974-03       Impact factor: 22.682

4.  Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis.

Authors:  P L Golding; M Smith; R Williams
Journal:  Am J Med       Date:  1973-12       Impact factor: 4.965

5.  High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis.

Authors:  R M Galbraith; M Smith; R M Mackenzie; D E Tee; D Doniach; R Williams
Journal:  N Engl J Med       Date:  1974-01-10       Impact factor: 91.245

6.  Association of autoimmune active chronic hepatitis with HL-A1,8.

Authors:  I R Mackay; P J Morris
Journal:  Lancet       Date:  1972-10-14       Impact factor: 79.321

7.  Effect of prednisone on the survival of patients with cirrhosis of the liver. A report from the Copenhagen Study Group for Liver Diseases.

Authors: 
Journal:  Lancet       Date:  1969-01-18       Impact factor: 79.321

8.  Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.

Authors:  G C Cook; R Mulligan; S Sherlock
Journal:  Q J Med       Date:  1971-04

9.  Incidence of coeliac disease in the West of Ireland.

Authors:  M Mylotte; B Egan-Mitchell; C F McCarthy; B McNicholl
Journal:  Br Med J       Date:  1973-03-24

10.  Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared.

Authors:  W H Summerskill; M G Korman; H V Ammon; A H Baggenstoss
Journal:  Gut       Date:  1975-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.